Pentraxin 3 in the cerebrospinal fluid during central nervous system infections: A retrospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,17 MB, PDF-dokument

The present study describes diagnostic and prognostic abilities of Cerebrospinal fluid (CSF) Pentraxin 3 (PTX3) in central nervous system (CNS) infections. CSF PTX3 was measured retrospectively from 174 patients admitted under suspicion of CNS infection. Medians, ROC curves and Youdens index was calculated. CSF PTX3 was significantly higher among all CNS infections and undetectable in most of the patients in the control group, and significantly higher in bacterial infections compared to viral and Lyme infections. No association was found between CSF PTX3 and Glasgow Outcome Score. PTX3 in the CSF can distinguish bacterial infection from viral and Lyme infections and non-CNS infections. Highest levels were found in bacterial meningitis. No prognostic abilities were found.

OriginalsprogEngelsk
Artikelnummere0282004
TidsskriftPLoS ONE
Vol/bind18
Udgave nummer3 March
ISSN1932-6203
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
Receiver of grant: MMT Funder: Nordsjællands Hospital Url: https://www. nordsjaellandshospital.dk/forskning/Sider/default. aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Publisher Copyright:
© 2023 Thomsen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ID: 341274829